[174 Pages Report] The global Orthopedic Imaging Equipment Market was valued at US$ 9.8 Billion in 2021 and is expected to reach US$ 14.6 Billion by 2031. The increasing number of accidents and sports injuries resulting in fractures and bone injuries is boosting the need for orthopedic diagnostic imaging.
| Data Points | Market Insights |
|---|---|
| Orthopedic Imaging Equipment Market Value 2020 | US$ 9.3 Billion |
| Orthopedic Imaging Equipment Market Market Value 2031 | US$ 14.6 Billion |
| CAGR 2021 to 2031 | 4.0% |
| Share of Top 5 Countries | 58.6% |
| Key Players | General Electric Healthcare Limited; Siemens AG; Esaote SPA; Hitachi Ltd; Koninklijke Philips N.V; PLANMED OY; EOS imaging |
Imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have opened new therapy possibilities with little morbidity. The increasing prevalence of orthopedic diseases such as osteoporosis, arthritis, elbow pain, and others have increased the demand for diagnosis and diagnostic equipment across the globe.
According to the Centers for Disease Control and Prevention (CDC), in The USA, around 72 million people will be affected by arthritis by 2030. Against this backdrop, demand for orthopedic imaging equipment is expected to bolster in the USA, making it one of the most lucrative pockets in the global market.
The orthopedic imaging equipment market holds nearly 31% of the medical imaging equipment market, totaling US$ 29.5 Billion by the end of 2031. There have been significant developments in medical imaging technology and orthopedic imaging equipment devices.
Subsequently, increased rates of bone disease and accidents resulting in bone injuries are driving the need for effective orthopedic diagnostic imaging.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 4.84% |
| H1, 2022 Projected | 3.94% |
| H1, 2022 Outlook | 3.64% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 30 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 120 ↓ |
The global orthopaedic imaging equipment market is subject to devise regulations, product patents, licensing requirements, and quality and safety assessment, as per all the macro and industry standards.
The key developments in the market include the development of advanced 3D imaging and software modelling of the target imaging field. The market is highly influenced by the growing adoption of portable or hand-held imaging devices, and the utilization of predictive modelling to identify surgical interventional sites for enhanced patient compliance with treatment.
The H1-2022 outlook period in comparison to H1-2022 projected period showed negative growth in terms of Basis Point Share by 30 BPS. And in H1-2022, the market growth rate of orthopaedic imaging equipment is expected to fall by 120 basis point shares (BPS), as per FMI analysis
The market decline observed through the reduction in the BPS values is addressed by the risk of radiation exposure during imaging, lack of qualified professional workforce to operate advanced imaging modalities, and high initial equipment cost followed by subsequently high maintenance costs.
According to Future Market Insights, sales of orthopedic imaging equipment grew at a CAGR of 4.0% between 2016 and 2020. With the rising incidence of orthopedic diseases and bone injuries coupled with a growing geriatric population, sales are expected to reach US$ 14.6 Billion by the end of 2031.
According to a UN report, the geriatric population will increase from 9.3 % in 2020 to around 16% in 2050. This increase in population will result in more acute and chronic injuries. Hence, demand for orthopedic imaging equipment is expected to increase, boosting the market.
Additionally, the global prevalence of osteoarthritis (OA) is rapidly increasing. Also, there has been a noticeable increase in the obesity ratio across the globe. Being overweight increases the pressure exerted on joints such as the knee, causing tension and speeding up cartilage breakdown.
Hence, the risk of bone and chronic injuries is expected to accelerate over the coming years. This is expected to create growth opportunities for the orthopedic imaging equipment market players.
Consequently, there is also a significant shift in doctors’ preference towards innovative and advanced technologies such as advanced MRI and CT imaging techniques. Development in these techniques will result in increased demand in the market.
Further, the orthopedic imaging equipment market is expected to grow with the expansion of the healthcare industry and the surging need to discover novel technologies to effectively diagnose any issue.
Rising acceptance and quick expansion of new technologies, especially in emerging economies such as India and China will boost the market throughout the forecast period. Hence, leading companies are concentrating on introducing new products as well as research and development.
Considering this, FMI expects the global orthopedic imaging equipment market to expand at over a CAGR of 5.4%, in terms of volume, through 2021.
Currently, several developing and underdeveloped nations are lacking adequate imaging infrastructure to conduct tests and technology implementation. Developed nations such as the USA have better diagnostic imaging and use advanced imaging techniques.
However, with few reimbursement policies and a lack of healthcare infrastructure, the market in underdeveloped economies in Latin America is expected to witness headwinds in the upcoming years.
These economies lack widespread access to diagnostic imaging, limiting the sales in the orthopedic imaging equipment market.
Besides this, the high cost involved in the initial setup and installation of imaging equipment and broadband technology in remote locations might hamper the growth of the global orthopedic imaging equipment market.
Additionally, the chances of recovering the costs solely depend on the number of scans arriving per day. Hence, achieving break-even is quite uncertain and entails high risk. This is expected to be the major restraining factor in the orthopedic imaging equipment market.
Principal Consultant
In 2021, the USA is expected to account for about 89.2% of the North American orthopedic imaging equipment market. Growing incidence of arthritis, acute injuries, increasing geriatric population, and high per capita healthcare spending in the USA are some of the factors boosting the market.
Furthermore, government funding for the procurement of imaging equipment by various institutions in the USA will aid the expansion of the market.
As per FMI, the UK is expected to account for 13.1% of the Europe market by 2021. Growth in the country is attributable to the technological advancements in medical devices used in orthopedic imaging and favorable government policies.
As per the National Health Service (UK), more than ten million individuals suffer from arthritis or other joint-related diseases. The rising prevalence of such bone diseases will improve the demand for orthopedic imaging equipment and treatment, accelerating sales in the UK.
China is projected to witness growth at a 6.9% CAGR in East Asia throughout the forecast period, opines Future Market Insights.
The increasing geriatric population and growing prevalence of osteoarthritis and other bone diseases are propelling the growth of China's orthopedic imaging equipment market.
According to the World Health Organization (WHO), by 2040, the geriatric population is expected to grow by 28% in China.
Demand for orthopedic imaging equipment in India is expected to rise at an impressive 6.3% CAGR over the forecast period, finds Future Market Insights.
Increasing research and development activities, rapid growth in medical device technology, and increasing adoption of medical devices are aiding the growth of the orthopedic imaging equipment market in India.
By product, the X-ray system segment is anticipated to hold the maximum share of 28.0 % in 2021. The segment is expected to exhibit growth at 3.3% CAGR during the forecast period.
The demand for X-rays is expected to outpace the sales of other imaging equipment, owing to several advantages of X-rays such as easy availability, accessibility, and cost-effectiveness.
They are more accessible than MRI and can be used to identify injuries and masses within the body more quickly. X-rays are one of the most cost-effective and widely used imaging techniques across developing economies such as India and China.
In terms of indication, the acute injuries segment is projected to dominate the market. As per FMI, the segment is expected to account for 56.6% of the total market share in 2021.
Growth in the segment is underpinned by an increase in accidental cases, sports injuries, and bone dislocation across the globe. According to the research study on acute injuries, over 30 million children participate in organized sports activities, among them nearly 3.5 million undergo severe acute injuries.
More than 775,000 children are treated in hospital emergency rooms for such injuries, resulting in the need for advanced orthopedic imaging equipment.
In terms of end-user, hospitals, and radiology centers, collectively, hold over 60% of the market share in 2021 and this trend is expected to continue during the forecast period as well.
A growing number of standalone imaging centers is propelling the growth in the radiology centers segment. Also, independent imaging centers provide discounts in order to attract more people, aiding the growth of the segment.
In addition, the time it takes for patients to have an MRI or other imaging procedure in radiology centers is reduced. Hence, the adoption of orthopedic imaging equipment will increase in radiology centers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Companies in the orthopedic imaging equipment market are pursuing new product innovations and launches, regulatory approvals, and expansion of their product portfolios as key strategies.
Key players are also focusing on the development of advanced and cost-effective products establishing distribution agreements to expand their global footprints, especially in Asia Pacific.
Moreover, companies are targeting Indian and China markets by establishing manufacturing units in order to reduce manufacturing costs. For instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia and Pacific; East Asia; and Middle East & Africa (MEA) |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, Germany, The UK, France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Thailand, Indonesia, Australia, and New Zealand, Egypt, Turkey, South Africa, North Africa, and GCC Countries |
| Key Segments Covered | Product, Indication, End User, and Region |
| Key Companies Profiled | General Electric Healthcare Limited; Siemens AG; Esaote SPA; Hitachi Ltd; Koninklijke Philips N.V; Planmed OY; EOS imaging; Canon Medical Systems Corporation; Neusoft Corporation; Carestream Health |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
By Product:
By Indication:
By End-User:
By Region:
The global orthopedic imaging equipment market is worth US$ 9.8 Billion in 2021 and is set to expand by 1.5X over the next ten years.
The orthopedic imaging equipment market is expected to reach US$ 14.6 Billion, with sales increasing at a 4.0% CAGR by the end of 2031.
Sales in the orthopedic imaging equipment market are expected to increase owing to the rising government and private body initiatives and surging demand for 3D medical imaging equipment.
North America currently holds the largest market share in the orthopedic imaging equipment market globally. The region is expected to contribute over 30.5% of the sales in the orthopedic imaging equipment market. As per FMI, the USA is expected to spearhead the growth, surpassing US$ 2.5 Billion in 2021.
Japan’s market for orthopedic imaging equipment is expected to exhibit healthy growth at 4.3% CAGR during the forecast period.
The USA, Russia, Poland, China, and Japan are the top 5 countries driving the demand in the orthopedic imaging equipment market.
1. Executive Summary | Orthopaedic Imaging Equipment Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Technological Roadmap 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Key Development Trends 3.3. New Launches / Approvals 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Global GDP Growth Outlook 4.1.2. Global Healthcare Expenditure Outlook 4.1.3. Emerging Countries Healthcare and Development Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. Adoption of Device Product 4.2.2. Prevalence of Orthopaedic Disorders 4.2.3. Historical growth of key players 4.2.4. New product launches and approvals 4.2.5. COVID-19 Impact 4.2.6. Reimbursement scenario 4.2.7. Expansion by Leading Manufacturer in Emerging Geographies 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 5. Market Context 5.1. List of Manufacturers and Suppliers 5.2. Usage/ Adoption Analysis 5.3. Promotional Strategies by Key Manufacturer 5.4. Technological Advancements 5.5. Regulatory Scenario 5.6. Porter’s Analysis 5.7. PESTLE Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Product 6.4.2. Revenue By Indication 6.4.3. Revenue By End User 6.4.4. Revenue By Region 6.5. 2021 Market Scenario 7. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031 7.1. Historical Market Volume (Units) Analysis, 2016 to 2020 7.2. Current and Future Market Volume (Units) Projections, 2021 to 2031 7.2.1. Y-o-Y Growth Trend Analysis 8. Market -Pricing Analysis 8.1. Regional Pricing Analysis By Indication 8.2. Pricing Break-up 8.2.1. Manufacturer-Level Pricing 8.2.2. Distributor Level Pricing 8.3. Average Pricing Analysis Benchmark 9. Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast, 2021 to 2031 9.1. Historical Market Value (US$ Million) Analysis, 2016 to 2020 9.2. Current and Future Market Value (US$ Million) Projections, 2021 to 2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2016 to 2020 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2021 to 2031 10.3.1. X-Ray Systems 10.3.2. CT-Scanner 10.3.3. Orthopaedic Imaging Equipment 10.3.4. EOS Imaging Systems 10.3.5. Ultrasound 10.3.6. Nuclear Imaging Systems 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis, By Indication, 2016 to 2020 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2021 to 2031 11.3.1. Acute injuries 11.3.1.1. Sports injuries 11.3.1.2. Trauma cases 11.3.2. Chronic Disorders 11.3.2.1. Osteoarthritis 11.3.2.2. Osteoporosis 11.3.2.3. Prolapsed Disc 11.3.2.4. Degenerative joint diseases 11.3.3. Market Attractiveness Analysis By Indication 12. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2016 to 2020 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2021 to 2031 12.3.1. Hospitals 12.3.2. Radiology Centers 12.3.3. Emergency Care Facility 12.3.4. Ambulatory Surgical Centres 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2016 to 2020 13.3. Current Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2021 to 2031 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 14.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 14.3.1. By Country 14.3.1.1. The USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 15.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 16.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 16.3.1. By Country 16.3.1.1. The UK 16.3.1.2. Germany 16.3.1.3. France 16.3.1.4. Italy 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Indication 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 17.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Indication 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 18.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.1.4. Rest of East Asia 18.3.2. By Product 18.3.3. By Indication 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 19.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Indication 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020 20.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Indication 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 21. Countries Level Market Analysis 2021 & 2031 21.1. Introduction 21.1.1. Market Value Proportion Analysis, By Key Countries 21.1.2. Global Vs. Country Growth Comparison 21.1.3. Pricing Analysis 21.2. The USA Market Analysis 21.2.1. By Product 21.2.2. By Indication 21.2.3. By End User 21.3. Canada Market Analysis 21.3.1. By Product 21.3.2. By Indication 21.3.3. By End User 21.4. Mexico Market Analysis 21.4.1. By Product 21.4.2. By Indication 21.4.3. By End User 21.5. Brazil Market Analysis 21.5.1. By Product 21.5.2. By Indication 21.5.3. By End User 21.6. The UK Market Analysis 21.6.1. By Product 21.6.2. By Indication 21.6.3. By End User 21.7. Germany Market Analysis 21.7.1. By Product 21.7.2. By Indication 21.7.3. By End User 21.8. France Market Analysis 21.8.1. By Product 21.8.2. By Indication 21.8.3. By End User 21.9. Italy Market Analysis 21.9.1. By Product 21.9.2. By Indication 21.9.3. By End User 21.10. Spain Market Analysis 21.10.1. By Product 21.10.2. By Indication 21.10.3. By End User 21.11. BENELUX Market Analysis 21.11.1. By Product 21.11.2. By Indication 21.11.3. By End User 21.12. Russia Market Analysis 21.12.1. By Product 21.12.2. By Indication 21.12.3. By End User 21.13. China Market Analysis 21.13.1. By Product 21.13.2. By Indication 21.13.3. By End User 21.14. Japan Market Analysis 21.14.1. By Product 21.14.2. By Indication 21.14.3. By End User 21.15. South Korea Market Analysis 21.15.1. By Product 21.15.2. By Indication 21.15.3. By End User 21.16. India Market Analysis 21.16.1. By Product 21.16.2. By Indication 21.16.3. By End User 21.17. Indonesia Market Analysis 21.17.1. By Product 21.17.2. By Indication 21.17.3. By End User 21.18. Thailand Market Analysis 21.18.1. By Product 21.18.2. By Indication 21.18.3. By End User 21.19. Malaysia Market Analysis 21.19.1. By Product 21.19.2. By Indication 21.19.3. By End User 21.20. Australia Market Analysis 21.20.1. By Product 21.20.2. By Indication 21.20.3. By End User 21.21. New Zealand Market Analysis 21.21.1. By Product 21.21.2. By Indication 21.21.3. By End User 21.22. GCC Countries Market Analysis 21.22.1. By Product 21.22.2. By Indication 21.22.3. By End User 21.23. Turkey Market Analysis 21.23.1. By Product 21.23.2. By Indication 21.23.3. By End User 21.24. South Africa Market Analysis 21.24.1. By Product 21.24.2. By Indication 21.24.3. By End User 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Concentration 22.4. Market Presence Analysis 22.4.1. By Regional Footprint of Players 22.4.2. Product foot print by Players 22.4.3. Channel foot print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. GE Healthcare 23.3.1.1. Overview 23.3.1.2. Product Portfolio 23.3.1.3. Analyst Commentary 23.3.1.4. Key Financials 23.3.1.5. Recent Developments 23.3.1.6. Profitability by Market Segments (Product / Channel / Region) 23.3.1.7. Sales Footprint 23.3.1.8. Strategy Overview 23.3.1.8.1. Marketing Strategy 23.3.1.8.2. Product Strategy 23.3.1.8.3. Channel Strategy 23.3.2. Koninklijke Philips N.V. 23.3.2.1. Overview 23.3.2.2. Product Portfolio 23.3.2.3. Analyst Commentary 23.3.2.4. Key Financials 23.3.2.5. Recent Developments 23.3.2.6. Profitability by Market Segments (Product / Channel / Region) 23.3.2.7. Sales Footprint 23.3.2.8. Strategy Overview 23.3.2.8.1. Marketing Strategy 23.3.2.8.2. Product Strategy 23.3.2.8.3. Channel Strategy 23.3.3. Siemens Healthineers 23.3.3.1. Overview 23.3.3.2. Product Portfolio 23.3.3.3. Analyst Commentary 23.3.3.4. Key Financials 23.3.3.5. Recent Developments 23.3.3.6. Profitability by Market Segments (Product / Channel / Region) 23.3.3.7. Sales Footprint 23.3.3.8. Strategy Overview 23.3.3.8.1. Marketing Strategy 23.3.3.8.2. Product Strategy 23.3.3.8.3. Channel Strategy 23.3.4. Esaote SPA 23.3.4.1. Overview 23.3.4.2. Product Portfolio 23.3.4.3. Analyst Commentary 23.3.4.4. Key Financials 23.3.4.5. Recent Developments 23.3.4.6. Profitability by Market Segments (Product / Channel / Region) 23.3.4.7. Sales Footprint 23.3.4.8. Strategy Overview 23.3.4.8.1. Marketing Strategy 23.3.4.8.2. Product Strategy 23.3.4.8.3. Channel Strategy 23.3.5. Canon Medical Systems, Inc., 23.3.5.1. Overview 23.3.5.2. Product Portfolio 23.3.5.3. Analyst Commentary 23.3.5.4. Key Financials 23.3.5.5. Recent Developments 23.3.5.6. Profitability by Market Segments (Product / Channel / Region) 23.3.5.7. Sales Footprint 23.3.5.8. Strategy Overview 23.3.5.8.1. Marketing Strategy 23.3.5.8.2. Product Strategy 23.3.5.8.3. Channel Strategy 23.3.6. Hitachi Medical Systems 23.3.6.1. Overview 23.3.6.2. Product Portfolio 23.3.6.3. Analyst Commentary 23.3.6.4. Key Financials 23.3.6.5. Recent Developments 23.3.6.6. Profitability by Market Segments (Product / Channel / Region) 23.3.6.7. Sales Footprint 23.3.6.8. Strategy Overview 23.3.6.8.1. Marketing Strategy 23.3.6.8.2. Product Strategy 23.3.6.8.3. Channel Strategy 23.3.7. PLANMED OY 23.3.7.1. Overview 23.3.7.2. Product Portfolio 23.3.7.3. Analyst Commentary 23.3.7.4. Key Financials 23.3.7.5. Recent Developments 23.3.7.6. Profitability by Market Segments (Product / Channel / Region) 23.3.7.7. Sales Footprint 23.3.7.8. Strategy Overview 23.3.7.8.1. Marketing Strategy 23.3.7.8.2. Product Strategy 23.3.7.8.3. Channel Strategy 23.3.8. EOS imaging 23.3.8.1. Overview 23.3.8.2. Product Portfolio 23.3.8.3. Analyst Commentary 23.3.8.4. Key Financials 23.3.8.5. Recent Developments 23.3.8.6. Profitability by Market Segments (Product / Channel / Region) 23.3.8.7. Sales Footprint 23.3.8.8. Strategy Overview 23.3.8.8.1. Marketing Strategy 23.3.8.8.2. Product Strategy 23.3.8.8.3. Channel Strategy 23.3.9. Neusoft Corporation 23.3.9.1. Overview 23.3.9.2. Product Portfolio 23.3.9.3. Analyst Commentary 23.3.9.4. Key Financials 23.3.9.5. Recent Developments 23.3.9.6. Profitability by Market Segments (Product / Channel / Region) 23.3.9.7. Sales Footprint 23.3.9.8. Strategy Overview 23.3.9.8.1. Marketing Strategy 23.3.9.8.2. Product Strategy 23.3.9.8.3. Channel Strategy 23.3.10. Carestream Health 23.3.10.1. Overview 23.3.10.2. Product Portfolio 23.3.10.3. Analyst Commentary 23.3.10.4. Key Financials 23.3.10.5. Recent Developments 23.3.10.6. Profitability by Market Segments (Product / Channel / Region) 23.3.10.7. Sales Footprint 23.3.10.8. Strategy Overview 23.3.10.8.1. Marketing Strategy 23.3.10.8.2. Product Strategy 23.3.10.8.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Orthopaedic Imaging Equipment Market
